Overview
- Wednesday coverage highlights that clinicians should consider polyendocrine metabolic ovarian syndrome (PMOS) even when ultrasound does not show polycystic ovaries or when periods appear regular.
- PMOS is diagnosed using the Rotterdam criteria, which require any two of these features: ovulatory dysfunction, clinical or lab evidence of excess androgens, or polycystic ovarian morphology on ultrasound.
- Care should be multidisciplinary, combining lifestyle measures (diet, exercise, sleep), mental‑health support, metabolic screening, and medical options such as combined oral contraceptives, cyclical progesterone, metformin, antiandrogens, and ovulation induction when pregnancy is desired.
- First‑person reporting shows delayed diagnosis, body‑image distress, and heavy use of unproven social‑media remedies, underscoring gaps in clinician‑patient communication and the need for clearer public guidance.
- Experts warn diagnostic caution in adolescents because normal puberty can mimic PMOS and call for more research and public education so earlier, evidence‑based care can reduce long‑term metabolic and reproductive harm.